左主干冠脉疾病外科与经皮血运重建的匹配分析
单中心2010—2018年1091例左主干狭窄≥50%患者(898例CABG、193例PCI)的倾向性匹配分析显示,匹配后PCI组1年(77.61% vs 88.37%)和5年(48.77% vs 75.62%)生存率更低,5年MACCE更高(64.93% vs 32.56%)。风险校正后CABG仍与5年死亡风险(HR 0.40,95%CI 0.29-0.54)和MACCE风险(HR 0.37,95%CI 0.28-0.48)降低相关。
要点
- 左主干病变中CABG较PCI生存获益更优
- 匹配后PCI组5年MACCE、心梗和再次血运重建率更高
- 适合手术的左主干患者应优先考虑外科血运重建
核心结论
- 真实世界倾向性匹配分析显示,左主干冠脉疾病行CABG在生存和MACCE方面优于PCI,支持在合适手术候选者中采用外科血运重建。
研究设计与样本
- 单中心回顾性研究,纳入2010—2018年≥18岁、左主干狭窄≥50%行CABG或PCI的成人。
- 共识别1091例患者(898例CABG、193例PCI),采用贪婪倾向性匹配生成匹配队列,Kaplan-Meier比较生存,多变量Cox模型分析5年死亡和MACCE。
- 匹配后队列为215例CABG和134例PCI。
主要发现
- PCI组年龄更大(77岁 vs 68岁;P < .001)、心力衰竭更多(26.94% vs 13.14%;P < .001)、三支病变更少(42.49% vs 65.59%;P < .001)。
- 匹配分析中PCI组1年生存(77.61% vs 88.37%)和5年生存(48.77% vs 75.62%)均更低。
- PCI组5年MACCE更高(64.93% vs 32.56%;P < .001),心肌梗死(19.40% vs 7.44%;P = .001)和再次血运重建(26.12% vs 7.91%;P < .001)均更高。
- 风险校正后CABG与5年死亡风险降低(HR 0.40;95%CI 0.29-0.54;P < .001)和MACCE风险降低(HR 0.37;95%CI 0.28-0.48;P < .001)相关。
临床怎么用
- 对左主干冠脉疾病且适合手术的患者,CABG可作为优先血运重建策略以改善远期生存并减少MACCE。
局限性
- 为单中心真实世界回顾性分析,匹配后样本量有限,结论需结合患者个体手术风险综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Percutaneous coronary intervention (PCI) is being performed more frequently for left main coronary artery disease (LMCAD). This study evaluated a real-world propensity-matched analysis of surgical vs percutaneous revascularization for LMCAD. METHODS: Adults (≥18 years of age) at a single academic institution undergoing coronary artery bypass grafting (CABG) or PCI for left main stenosis greater than or equal to 50% between 2010 and 2018 were examined. Greedy propensity-matching techniques were used to generate well-matched cohorts, and Kaplan-Meier analysis was used to compare survival. Multivariable Cox models were created for 5-year mortality and major adverse cardiac and cerebrovascular events (MACCE). RESULTS: A total of 1091 patients with LMCAD were identified (898 CABG, 193 PCI). Patients undergoing PCI were significantly older (77 years of age vs 68 years of age; P < .001), more likely to have heart failure (26.94% vs 13.14%; P < .001), and less likely to have 3-vessel disease (42.49% vs 65.59%; P < .001). Propensity matching yielded 215 CABG and 134 PCI well-matched patients. In the matched analysis, 1-year (77.61% vs 88.37%) and 5-year (48.77% vs 75.62%) survival were lower with PCI. Rates of MACCE at 5 years were also higher with PCI (64.93% vs 32.56%; P < .001). Rates of both myocardial infarction (19.40% vs 7.44%; P = .001) and repeat revascularization (26.12% vs 7.91%; P < .001) were higher with PCI. After risk adjustment, CABG remained associated with reduced risk of mortality (hazard ratio, 0.40; 95% confidence interval, 0.29-0.54; P < .001) and MACCE (hazard ratio, 0.37; 95% confidence interval, 0.28-0.48; P < .001) at 5 years. CONCLUSIONS: This real-world, propensity-matched analysis demonstrates substantial advantages in survival and MACCE with CABG for LMCAD, supporting surgical revascularization in this clinical setting in appropriate operative candidates.
引用
- Huckaby LV, Sultan I, Ferdinand FD, et al. Matched Analysis of Surgical Versus Percutaneous Revascularization for Left Main Coronary Disease. Ann Thorac Surg. 2021. PMID: 33930354. doi:10.1016/j.athoracsur.2021.04.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。